PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (FR0010949404 — STNT), a medical technology company commercializing the world’s first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), today announced its first distribution contracts in South America.
Help employers find you! Check out all the jobs and post your resume.
